Johnson & Johnson Reaches $230M Settlement With New York To End Sale Of Opioids Nationwide
June 26, 2021 at 21:44 PM EDT
The company has said that it has not marketed opioids in the U.S. since 2015 and discontinued the business in 2020. JNJ did not admit liability in settling with New York State, Nassau, and Suffolk counties.
